Emergency Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Emergency Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Ann Emerg Med. 2020 Oct;76(4):405-412. doi: 10.1016/j.annemergmed.2020.05.022. Epub 2020 May 21.
We seek to describe the medical history and clinical findings of patients attending the emergency department (ED) with suspected coronavirus disease 2019 (COVID-19) and estimate the diagnostic accuracy of patients' characteristics for predicting COVID-19.
We prospectively enrolled all patients tested for severe acute respiratory syndrome coronavirus 2 by reverse-transcriptase polymerase chain reaction in our ED from March 9, 2020, to April 4, 2020. We abstracted medical history, physical examination findings, and the clinical probability of COVID-19 (low, moderate, and high) rated by emergency physicians, depending on their clinical judgment. We assessed diagnostic accuracy of these characteristics for COVID-19 by calculating positive and negative likelihood ratios.
We included 391 patients, of whom 225 had positive test results for severe acute respiratory syndrome coronavirus 2. Reverse-transcriptase polymerase chain reaction result was more likely to be negative when the emergency physician thought that clinical probability was low, and more likely to be positive when he or she thought that it was high. Patient-reported anosmia and the presence of bilateral B lines on lung ultrasonography had the highest positive likelihood ratio for the diagnosis of COVID-19 (7.58, 95% confidence interval [CI] 2.36 to 24.36; and 7.09, 95% CI 2.77 to 18.12, respectively). The absence of a high clinical probability determined by the emergency physician and the absence of bilateral B lines on lung ultrasonography had the lowest negative likelihood ratio for the diagnosis of COVID-19 (0.33, 95% CI 0.25 to 0.43; and 0.26, 95% CI 0.15 to 0.45, respectively).
Anosmia, emergency physician estimate of high clinical probability, and bilateral B lines on lung ultrasonography increased the likelihood of identifying COVID-19 in patients presenting to the ED.
我们旨在描述因疑似 2019 年冠状病毒病(COVID-19)而到急诊科就诊的患者的病史和临床发现,并评估患者特征对预测 COVID-19 的诊断准确性。
我们前瞻性纳入 2020 年 3 月 9 日至 2020 年 4 月 4 日期间在我院急诊科接受逆转录酶聚合酶链反应检测严重急性呼吸综合征冠状病毒 2 的所有患者。我们从病史、体检发现和急诊医师根据临床判断评估的 COVID-19 临床可能性(低、中、高)中提取数据。我们通过计算阳性和阴性似然比来评估这些特征对 COVID-19 的诊断准确性。
共纳入 391 例患者,其中 225 例严重急性呼吸综合征冠状病毒 2 检测结果为阳性。当急诊医师认为临床可能性低时,逆转录酶聚合酶链反应结果更可能为阴性,而当他或她认为临床可能性高时,结果更可能为阳性。患者自述嗅觉丧失和肺部超声出现双侧 B 线对 COVID-19 的诊断具有最高的阳性似然比(7.58,95%置信区间 [CI] 2.36 至 24.36;7.09,95%CI 2.77 至 18.12)。当急诊医师确定临床可能性低和肺部超声未见双侧 B 线时,对 COVID-19 的诊断具有最低的阴性似然比(0.33,95%CI 0.25 至 0.43;0.26,95%CI 0.15 至 0.45)。
嗅觉丧失、急诊医师评估的高临床可能性和肺部超声出现双侧 B 线增加了急诊科就诊患者识别 COVID-19 的可能性。